NCT02689271View on ClinicalTrials.gov

CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr

CompletedOBSERVATIONAL
Enrollment

365

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Prostate Cancer
Interventions
OTHER

MRI

VERDICT diffusion-weighted microstructure imaging sequence

Trial Locations (1)

NW12BU

University College London Hospital, Camden

All Listed Sponsors
lead

University College, London

OTHER

NCT02689271 - CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr | Biotech Hunter | Biotech Hunter